aggregation raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
This page was last updated on 2025-12-21 and is reviewed periodically as new material appears.
Research-grade material circulates through suppliers that differ widely in documentation and testing practice, so a certificate of analysis is a starting point rather than proof of quality. Independent verification typically repeats chromatographic purity and mass confirmation on the received lot, and compares results against a retained reference standard. Regulatory status varies by jurisdiction, and a substance cleared as a medicine is not interchangeable with a research chemical of the same name. Open questions include how closely non-pharmaceutical lots match approved material in impurity profile and in aggregate content.
Solid tirzepatide is handled as a lyophilised, hygroscopic peptide powder that should be kept desiccated, protected from light, and stored frozen, typically at or below minus twenty degrees Celsius for long-term retention. Material left at ambient temperature for extended periods can take up moisture, which promotes aggregation and deamidation. Commercial liquid presentations are kept refrigerated between two and eight degrees Celsius and are not frozen. Reconstituted laboratory solutions are generally held cold and used within a short window because hydrolysis and oxidation continue slowly in solution.
Identity and purity are usually established with reversed-phase high-performance liquid chromatography for the main peak and with mass spectrometry for the observed molecular mass. Peptide mapping after enzymatic digestion confirms the primary sequence, while amino acid analysis provides a quantitative composition check. Size-exclusion chromatography and ion-exchange chromatography are used to look for aggregates and charge variants. Water content, residual solvents, and counter-ion content are measured separately, since a lyophilised powder is often reported on an as-is basis unless a correction is applied.
The GIP receptor is expressed in pancreatic islets, adipose tissue, and the central nervous system, while GLP-1 receptors are found in pancreatic islets, the gastrointestinal tract, and the brain. Activation of both receptors can enhance glucose-dependent insulin secretion and reduce glucagon release. The relative contribution of each receptor to the overall pharmacological effect remains an area of ongoing investigation. Preclinical studies suggest that GIP receptor agonism may modulate appetite and energy balance, but the precise mechanisms in humans are not fully established.
In clinical research, tirzepatide has been studied in randomized controlled trials for glycemic control and body weight reduction. These trials typically measure changes in hemoglobin A1c and body weight over periods of several months. The drug is administered by subcutaneous injection, and its pharmacokinetic profile supports once-weekly dosing. Post-marketing surveillance continues to evaluate long-term outcomes and rare adverse events.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white powder | Lyophilised solid, may form a loose cake |
| Solubility class | Soluble in water | Practically insoluble in nonpolar solvents |
| Storage temperature, solid | -20 °C or below | Desiccated and protected from light |
| Storage temperature, liquid | 2-8 °C | Refrigerated, not frozen |
| Typical identity method | LC-MS | Observed mass compared with calculated mass |
Identity and purity are assessed by reversed-phase high-performance liquid chromatography, with mass confirmation by electrospray ionisation mass spectrometry. Peptide mapping after enzymatic digestion verifies the primary sequence. Size-exclusion chromatography quantifies aggregates, while circular dichroism provides a secondary-structure fingerprint. Bioanalytical quantification in plasma uses immunoassay or LC-MS/MS. Reported purity for research-grade lots is commonly 95 percent or higher, and residual water content is checked by Karl Fischer titration.
As a peptide, tirzepatide is handled as a lyophilised solid in research settings and as a preserved solution in finished products. Aqueous solubility is pH dependent and reaches a minimum near the isoelectric point, which lies close to pH 5.4. Stock solutions are typically prepared in neutral or slightly basic buffer to limit precipitation. The solid is hygroscopic and should be equilibrated to room temperature before opening so that condensation does not form on the powder surface.
The compound first appeared in the scientific literature as an investigational agent for type 2 diabetes. Clinical development proceeded through phase 1, phase 2, and phase 3 programs that measured glycemic control as a primary endpoint while recording body weight as a secondary outcome. Regulatory approval in the United States followed in 2022 for glycemic control, and a separate indication for chronic weight management was added later. Subsequent trials have examined cardiovascular outcomes in adults with elevated cardiovascular risk. Debates continue over how much of the observed effect derives from each receptor arm.
Structural work on the molecule centers on a C20 fatty diacid moiety attached through a linker to the peptide backbone. This side chain promotes reversible binding to serum albumin, which slows renal clearance and supports a prolonged action profile. The peptide backbone incorporates aminoisobutyric acid substitutions that limit recognition by digestive enzymes. Together these modifications produce a molecule that is stable enough for subcutaneous delivery but still dependent on careful manufacturing control. Analytical characterization of the active pharmaceutical ingredient typically follows the conventions used for other synthetic peptides.
== Scoville organoleptic test == In the Scoville organoleptic test, an exact weight of dried pepper is dissolved in alcohol to extract the heat components (capsaicinoids), then diluted in a solution of sugar water. Decreasing concentrations of the extracted capsaicinoids are given to a panel of five trained tasters, until a majority (at least three) can no longer detect the heat in a dilution. The heat level is based on this dilution, rated in multiples of 100 SHU. Another source using subjective assessment stated, "Conventional methods used in determining the level of pungency or capsaicin concentration are using a panel of tasters (Scoville organoleptic test method). ... Pepper pungency is measured in Scoville heat units (SHU). This measurement is the highest dilution of a chili pepper extract at which heat can be detected by a taste panel." A weakness of the Scoville organoleptic test is its imprecision due to human subjectivity, depending on the taster's palate and number of mouth heat receptors, which vary widely among subjects. Another shortcoming is sensory fatigue; the palate is quickly desensitized to capsaicinoids after tasting a few samples within a short time period. Results vary widely (up to ± 50%) between laboratories.
"The terms mental health promotion and prevention have often been confused. Promotion is defined as intervening to optimize positive mental health by addressing determinants of positive mental health (i.e. protective factors) before a specific mental health problem has been identified, with the ultimate goal of improving the positive mental health of the population. Mental health prevention is defined as intervening to minimize mental health problems (i.e. risk factors) by addressing determinants of mental health problems before a specific mental health problem has been identified in the individual, group, or population of focus with the ultimate goal of reducing the number of future mental health problems in the population." In order to improve mental health, the root of the issue has to be resolved. "Prevention emphasizes the avoidance of risk factors; promotion aims to enhance an individual's ability to achieve a positive sense of self-esteem, mastery, well-being, and social inclusion." Mental health promotion attempts to increase protective factors and healthy behaviors that can help prevent the onset of a diagnosable mental disorder and reduce risk factors that can lead to the development of a mental disorder. Yoga is an example of an activity that calms one's entire body and nerves.
=== Chemoresistance === In some cases, the characteristics of CAF provide therapeutic resistance. Soluble factor resistance occurs when CAF either directly secrete signals (cytokines or growth factors) or influence the cells around them to give off similar signals, which reduce the efficacy of therapeutic drugs. For instance, this can either be done by an increased secretion of antiapoptotic factors or by altering the cell environment (e.g. pH) to counteract the actions of the drug. Another form is cell adhesion- mediated drug resistance. This involves the tight attachment of neoplastic cells to the extracellular matrix or stromal cells. For example, secretion of TGF-beta allows cancerous cells to bind more successfully to the extracellular matrix thus evading the action of some cancer drugs.
== Further reading == Robertson, G. L. (2013). Food Packaging: Principles & Practice. CRC Press. ISBN 978-1-4398-6241-4 Yam, K. L., Encyclopedia of Packaging Technology, John Wiley & Sons, 2009, ISBN 978-0-470-08704-6 Harwell, Edward M., Packaging and Displaying Meats in Self-Service Meat Markets, United States Department of Agriculture. June 1953
Sources: en.wikipedia.org
=== 12-HHT is a BLT2 receptor agonist === Leukotriene B4 (LTB4) is an arachidonic acid metabolite made by the 5-lipoxygenase enzyme pathway. It activates cells through both its high affinity (dissociation constant [Kd] of 0.5–1.5 nM) Leukotriene B44 receptor 1 (BLT1 receptor) and its low affinity BLT2 receptor (Kd=23 nM); both receptors are G protein-coupled receptors that, when ligand-bound, activate cells by releasing the Gq alpha subunit and pertussis toxin-sensitive Gi alpha subunit from heterotrimeric G proteins. BLT1 receptor has a high degree of ligand-binding specificity: among a series of hydroxylated eicosanoid metabolites of arachidonic acid, it binds only LTB4, 20-hydroxy-LTB4, and 12-epi-LTB4; among this same series, BLT2 receptor has far less specificity in that it binds not only LTB4, 20-hydroxy-LTB4, and 12-epi-LTB4, but also 12(R)-HETE and 12(S)-HETE (i.e. the two stereoisomers of 12-hydroxyeicosatetraenoic acid) and 15(S)-HpETE and 15(S)-HETE (i.e. the two stereoisomers of 15-hydroxyicosatetraenoic acid). The BLT2 receptor's relative affinities for finding LTB4, 12(S)-HETE, 12(S)-HpETE, 12(R)-HETE, 15(S)-HETE, and 20-hydroxy-LTB4 are ~100, 10, 10, 3, 3, and 1, respectively. All of these binding affinities are considered to be low and therefore indicating that some unknown ligand(s) might bind BLT2 with high affinity. In 2009, 12-HHT was found to bind to the BLT2 receptor with ~10-fold higher affinity than LTB4; 12-HHT did not bind to the BLT1 receptor.
== Clinical significance == Recessive mutations in NADK2 cause NADK2 deficiency, an inherited metabolic disorder characterized by neurological symptoms including hypotonia, developmental delay, ataxia, and encephalopathy. Affected individuals also show metabolic abnormalities, including hyperlysinemia and impaired fat oxidation with elevated C10:2-carnitine levels, consistent with secondary 2,4-dienoyl-CoA reductase deficiency. Cancer cells are exposed to elevated oxidative stress and are consequently highly dependent on mitochondrial NADPH to maintain redox homeostasis. NADK2 is essential for mitochondrial NADPH production and has therefore been proposed as a potential target to increase oxidative stress and sensitize cancer cells to apoptosis. A lack of NADK2 additionally impairs proline biosynthesis, rendering cancer cells dependent on exogenous proline for proliferation. NADK2 has been linked to Alzheimer's disease. Tau oligomers upregulate NADK2 in human neurons, leading to increased mitochondrial NADPH production, which in turn increases LRP1 expression and promotes tau uptake, creating a self-reinforcing cycle.
Ancient pyramidical structures, mausoleums, ruined cities and stone walls, such as the Wargaade Wall, are evidence of an old civilisation that once thrived in the Somali peninsula. This civilisation enjoyed a trading relationship with ancient Egypt and Mycenaean Greece since the second millennium BC, supporting the hypothesis that Somalia or adjacent regions were the location of the ancient Land of Punt. The Puntites native to the region traded myrrh, spices, gold, ebony, short-horned cattle, ivory and frankincense with the Egyptians, Phoenicians, Babylonians, Indians, Chinese and Romans through their commercial ports. An Egyptian expedition sent to Punt by the 18th dynasty Queen Hatshepsut is recorded on the temple reliefs at Deir el-Bahari, during the reign of the Puntite King Parahu and Queen Ati. In the classical era, the Macrobians, who may have been ancestral to Somalis, established a powerful kingdom that ruled large parts of modern Somalia. They were reputed for their longevity and wealth, and were said to be the "tallest and handsomest of all men". The Macrobians were warrior herders and seafarers. According to Herodotus' account, the Persian Emperor Cambyses II, upon his conquest of Egypt in 525 BC, sent ambassadors to Macrobia, bringing luxury gifts for the Macrobian king to entice his submission.
Louisville hotspot (23) 53°36′S 140°36′W, w= 1 az= 316° ±5° rate= 67 ±5 mm/yr Possibly related to the Ontong Java Plateau (125–120 Ma). Foundation hotspot/Ngatemato seamounts (57) 37°42′S 111°06′W, w= 1 az= 292° ±3° rate= 80 ±6 mm/yr Macdonald hotspot (24) 29°00′S 140°18′W, w= 1 az= 289° ±6° rate= 105 ±10 mm/yr North Austral/President Thiers (President Thiers Bank, 58) 25°36′S 143°18′W, w= (1.0) az= 293° ± 3° rate= 75 ±15 mm/yr Arago hotspot (Arago Seamount, 59) 23°24′S 150°42′W, w= 1 az= 296° ±4° rate= 120 ±20 mm/yr Maria/Southern Cook hotspot (Îles Maria, 60) 20°12′S 153°48′W, w= 0.8 az= 300° ±4° Samoa hotspot (35) 14°30′S 168°12′W, w= 0.8 az= 285°±5° rate= 95 ±20 mm/yr Crough hotspot (Crough Seamount, 61) 26°54′S 114°36′W, w= 0.8 az= 284° ± 2° Pitcairn hotspot (31) 25°24′S 129°18′W, w= 1 az= 293° ±3° rate= 90 ±15 mm/yr Society/Tahiti hotspot (38) 18°12′S 148°24′W, w= 0.8 az= 295°±5° rate= 109 ±10 mm/yr Marquesas hotspot (26) 10°30′S 139°00′W, w= 0.5 az= 319° ±8° rate= 93 ±7 mm/yr Caroline hotspot (4) 4°48′N 164°24′E, w= 1 az= 289° ±4° rate= 135 ±20 mm/yr Hawaii hotspot (12) 19°00′N 155°12′W, w= 1 az= 304° ±3° rate= 92 ±3 mm/yr Socorro/Revillagigedos hotspot (37) 19°00′N 111°00′W Guadalupe hotspot (11) 27°42′N 114°30′W, w= 0.8 az= 292° ±5° rate= 80 ±10 mm/yr Cobb hotspot (5) 46°00′N 130°06′W, w= 1 az= 321° ±5° rate= 43 ±3 mm/yr Bowie/Pratt-Welker hotspot (3) 53°00′N 134°48′W, w= 0.8 az= 306° ±4° rate= 40 ±20 mm/yr
== History == Cell display systems were first used in 1985, when peptides were genetically fused with proteins displayed on the M13 bacteriophage. Bacteriophage display is a commonly used cell display system, although it carries limitations in the size of proteins that can be displayed. Bacterial display was then introduced in 1986, allowing the surface display of larger proteins. Bacterial display systems were first introduced by Freudl et al. and Charbit et al. in 1986, when they used bacterial surface proteins OmpA and LamB to display peptides. Freudl et al. fused peptides with linkers with the ompA gene, causing the peptides to be expressed in the OmpA proteins. They showed that the proteins were now subject to cleavage by proteinase K. The non-OmpA peptides inserted were therefore a target of proteinase K. Insertion of the foreign peptides did not affect bacterial cell growth. Charbit et al. firstly defined the areas of the LamB protein that were "permissive" for foreign petide insertion (ie that did not lead to a complete loss of functionality of the protein). Then, they explored the versatility of the permissive sites (size limit, nature of the epitope,...) that were all located in surface-exposed loops of the trimeric outer membrane porin, aiming at developing multivalent live bacterial vaccines. This was the first evidence of using bacterial surface display techniques to express proteins on the surface of cells, without altering the function of the cell.
Sources: en.wikipedia.org
=== Pharmaceuticals === Over 30 nitrile-containing pharmaceuticals are currently marketed for a diverse variety of medicinal indications with more than 20 additional nitrile-containing leads in clinical development. The types of pharmaceuticals containing nitriles are diverse, from vildagliptin, an antidiabetic drug, to anastrozole, which is the gold standard in treating breast cancer. In many instances the nitrile mimics functionality present in substrates for enzymes, whereas in other cases the nitrile increases water solubility or decreases susceptibility to oxidative metabolism in the liver. The nitrile functional group is found in several drugs.
The SADC has specifically emphasised the importance of combating non-traditional maritime threats as part of the 2050 Integrated Maritime Strategy. The Bay of Bengal Initiative for Multi-Sectoral Technical and Economic Cooperation (BIMSTEC), has enabled the states within the Bay of Bengal to create greater maritime security through collaboration between countries. Furthermore, BIMSTEC has launched a Convention on Cooperation in Combating International Terrorism, Organised Crime and Illicit Drug Trafficking. This facilitates regional cooperation specific to the illicit drug trade, and provides the region with the foundations to develop their response further. The existing regional and individual responses by states have, in practice, been limited to seizure-based responses. This is due to gaps in the current legal infrastructure, which prevent effective prosecution of smugglers following drug seizures. Huge drug seizures have been made by both the Combined Maritime Forces (CMF) and the Combined task force (CTF), such as when the CTF successfully seized 6.2 tonnes of hashish over two days. However, gaps in the current laws prevent further action. One such example is Article 110 of the UNSC Law of the Sea Convention 1982, which does not include a suspicion of drug smuggling as a legitimate reason to board a vessel without gaining permission from the ship’s flagged country. This has decreased the amount of possible seizures, and gaining permission to board vessels is complicated by insufficient regional cooperation within the criminal justice system.
== Scholarly works == Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis, Published in Travel Medicine and Infectious Disease, Volume 34, March–April 2020 Central nervous system involvement by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), Published in The Journal of Medical Virology, Volume 92 Issue 7, July 2020 Probable Zoonotic Leprosy in the Southern United States, Published in the New England Journal of Medicine, April 28, 2011. ChikDenMaZika Syndrome: the challenge of diagnosing arboviral infections in the midst of concurrent epidemics, Published in Annals of Clinical Microbiology and Antimicrobials, Article 42, July 22, 2016. Lobomycosis in Venezuela, Published in the International Journal of Dermatology, Volume 46, Issue 22, February 2007. Venezuela's humanitarian crisis, resurgence of vector-borne diseases, and implications for spillover in the region, Published in The Lancet, Volume 19, Issue 5, May 2019.
=== Other branches === Biotechnology, Bioluminescence, Molecular chemistry, Enzymatic chemistry, Genetic engineering, Pharmaceuticals, Endocrinology, Neurochemistry, Hematology, Nutrition, Photosynthesis, Environmental, Toxicology, Structural biology
Sources: en.wikipedia.org
It is normally kept frozen, desiccated, and away from light, with brief warming to room temperature before opening to limit condensation. Repeated freeze-thaw cycles are avoided because they stress the peptide. Once in solution, the material is held cold and used promptly.
Mass spectrometry gives the observed molecular mass, which is compared with the calculated value for the expected sequence. Reversed-phase chromatography shows retention behaviour and main peak purity. Peptide mapping adds sequence-level confirmation when the question requires it.
Typical entries include appearance, chromatographic purity as area percent, observed mass, water or residual solvent content, and the analytical methods used. The document reflects the lot tested and the laboratory that performed the work. It does not by itself establish that the delivered vial matches the tested lot.
It activates both GIP and GLP-1 receptors. This dual action differentiates it from selective GLP-1 agonists.